These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36164552)

  • 1. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
    Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
    Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 reinfections during the Delta and Omicron waves.
    Morris CP; Eldesouki RE; Fall A; Gaston DC; Norton JM; Gallagher ND; Luo CH; Abdullah O; Klein EY; Mostafa HH
    JCI Insight; 2022 Oct; 7(20):. PubMed ID: 36048527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Reinfections in Health-Care Workers, 1 March 2020-31 January 2023.
    Cegolon L; Magnano G; Negro C; Larese Filon F;
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515237
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
    Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
    JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity of SARS-CoV-2 infection and vaccines against medically attended symptomatic omicron BA.4, BA.5, and XBB reinfections in Singapore: a national cohort study.
    Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
    Lancet Infect Dis; 2023 Jul; 23(7):799-805. PubMed ID: 36924786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022.
    Bastard J; Taisne B; Figoni J; Mailles A; Durand J; Fayad M; Josset L; Maisa A; van der Werf S; Parent du Châtelet I; Bernard-Stoecklin S
    Euro Surveill; 2022 Mar; 27(13):. PubMed ID: 35362406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Reinfection With Different SARS-CoV-2 Variants in Children, Ohio, United States.
    Wang H; Wright T; Everhart K; Oyeniran SJ; Mejias A; Leber AL
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):198-204. PubMed ID: 37004190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Increase in Suspected SARS-CoV-2 Reinfections, Clark County, Nevada, USA, December 2021.
    Ruff J; Zhang Y; Kappel M; Rathi S; Watkins K; Zhang L; Lockett C
    Emerg Infect Dis; 2022 Oct; 28(10):1977-1981. PubMed ID: 35969420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reinfection rate in a cohort of healthcare workers over 2 years of the COVID-19 pandemic.
    Guedes AR; Oliveira MS; Tavares BM; Luna-Muschi A; Lazari CDS; Montal AC; de Faria E; Maia FL; Barboza ADS; Leme MD; Tomazini FM; Costa SF; Levin AS
    Sci Rep; 2023 Jan; 13(1):712. PubMed ID: 36639411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study.
    Graham MS; Sudre CH; May A; Antonelli M; Murray B; Varsavsky T; Kläser K; Canas LS; Molteni E; Modat M; Drew DA; Nguyen LH; Polidori L; Selvachandran S; Hu C; Capdevila J; ; Hammers A; Chan AT; Wolf J; Spector TD; Steves CJ; Ourselin S
    Lancet Public Health; 2021 May; 6(5):e335-e345. PubMed ID: 33857453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.
    Zhang M; Cao L; Zhang L; Li X; Chen S; Zhang Y
    BMC Public Health; 2024 Feb; 24(1):496. PubMed ID: 38365671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022.
    Ma KC; Dorabawila V; León TM; Henry H; Johnson AG; Rosenberg E; Mansfield JA; Midgley CM; Plumb ID; Aiken J; Khanani QA; Auche S; Bayoumi NS; Bennett SA; Bernu C; Chang C; Como-Sabetti KJ; Cueto K; Cunningham S; Eddy M; Falender RA; Fleischauer A; Frank DM; Harrington P; Hoskins M; Howsare A; Ingaiza LM; Islam AS; Jensen SA; Jones JM; Kambach G; Kanishka F; Levin Y; Masarik JF; Meyer SD; Milroy L; Morris KJ; Olmstead J; Olsen NS; Omoike E; Patel K; Pettinger A; Pike MA; Reed IG; Slocum E; Sutton M; Tilakaratne BP; Vest H; Vostok J; Wang JS; Watson-Lewis L; Wienkes HN; Hagen MB; Silk BJ; Scobie HM
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(25):683-689. PubMed ID: 37347715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 reinfections in Mexico City: implications for public health.
    de Anda-Jáuregui G; Gómez-Romero L; Cañas S; Campos-Romero A; Alcántar-Fernández J; Cedro-Tanda A
    Front Public Health; 2023; 11():1321283. PubMed ID: 38419814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022.
    Sacco C; Petrone D; Del Manso M; Mateo-Urdiales A; Fabiani M; Bressi M; Bella A; Pezzotti P; Rota MC; Riccardo F;
    Euro Surveill; 2022 May; 27(20):. PubMed ID: 35593164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
    Sevillano G; Ortega-Paredes D; Loaiza K; Zurita-Salinas C; Zurita J
    Int J Infect Dis; 2021 Jul; 108():53-56. PubMed ID: 33930542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early SARS-CoV-2 Reinfections Involving the Same or Different Genomic Lineages, Spain.
    Rodríguez-Grande C; Estévez A; Palomino-Cabrera R; Molero-Salinas A; Peñas-Utrilla D; Herranz M; Sanz-Pérez A; Alcalá L; Veintimilla C; Catalán P; Martínez-Laperche C; Alonso R; Muñoz P; Pérez-Lago L; de Viedma DG;
    Emerg Infect Dis; 2023 Jun; 29(6):1154-1161. PubMed ID: 37130503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.
    Acuña-Castillo C; Barrera-Avalos C; Bachelet VC; Milla LA; Inostroza-Molina A; Vidal M; Luraschi R; Vallejos-Vidal E; Mella-Torres A; Valdés D; Reyes-López FE; Imarai M; Rojas P; Sandino AM
    Front Public Health; 2023; 11():1191377. PubMed ID: 37492136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.
    Freire-Neto FP; Teixeira DG; da Cunha DCS; Morais IC; Tavares CPM; Gurgel GP; Medeiros SDN; Santos DCD; Sales AO; Jeronimo SMB
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010337. PubMed ID: 36191040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.